Skip to content

The effect of intravenous acetaminophen on postoperative temperature after cardiac surgery with cardiopulmonary bypass

The effect of intravenous acetaminophen on postoperative temperature after cardiac surgery with cardiopulmonary bypass - The effect of acetaminophen on postoperative temperature after cardiac surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000033064
Enrollment
48
Registered
2018-06-21
Start date
2023-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients after cardiac surgery

Interventions

Acetaminophen is administered intravenously every 6 hours since 30 minutes after weaning from cardiopulmonary bypass. The amount of acetaminophen is 15 mg/kg. ( maximal dose: 1000mg ) Physiological s

Sponsors

Nagasaki University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients admitted to Nagasaki University Hospital to receive elective cardiac surgery with cardiopulmonary bypass

Exclusion criteria

Exclusion criteria: 1. preoperative liver dysfunction ( ALT > = 126 U/L or Child-Pugh score A, B or C) 2. preoperative renal dysfunction ( eGFR < = 30 mL/min/1.73m^2) 3. patients with allergic history against acetaminophen 4. patients with peptic ulcer 5. patients with severe hematologic disease 6. patients with history of aspirin-induced asthma 7. pregnant or breast-feeding women 8. preoperative use of steroids 9. re-operated patients 10. patients with re-induction of cardiopulmonary bypass during operation 11. patients undergoing re-operation because of postoperative hemorrhage 12. patients judged inappropriate

Design outcomes

Primary

MeasureTime frame
The highest temperature during 24 hours after ICU admission

Countries

Japan

Contacts

Public ContactSOJIRO MATSUMOTO

Nagasaki University Hospital Division of intensive care

s-matsumoto@nagasaki-u.ac.jp095-819-7200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026